Clinical trial
Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced…
NCT00354224 · Medical University of South Carolina, Other · Terminated
Key facts
| NCT number | NCT00354224 |
|---|---|
| Title | Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer |
| Official title | A Phase II Study of XELOX in Locally Advanced or Metastatic Gastric Cancer |
| Lead sponsor | Medical University of South Carolina, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, oxaliplatin |
| Enrollment | 10 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jul 20, 2006 |
| Last update posted | Jul 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: